Angle PLC 2022 AR2
The report details ANGLE plc's strategic and financial progress for the fiscal year ended December 31, 2022, highlighted by the ground-breaking FDA De Novo product clearance for its Parsortix PC1 Clinical System in metastatic breast cancer. The company established a global distribution network and expanded its pharma services business, securing repeat contracts and achieving ISO 15189 accreditation for its US clinical laboratory. Financially, ANGLE reported flat revenues of £1.0 million and an increased operating loss of £21.7 million due to planned investments in clinical studies and commercialization. To streamline operations and extend its cash runway into H2 2024, the company completed a £20.1 million capital raise and initiated the orderly wind-down of its Canadian facility.
Company: Angle PLC
Sector: Professional & technical services
Country: United Kingdom
Year: 2022
Type: AR2
Pages: 143
Back to company
Angle PLC
Annual Report And Financial Statements
The report details ANGLE plc's strategic and financial progress for the fiscal year ended December 31, 2022, highlighted by the ground-breaking FDA De Novo product clearance for its Parsortix PC1 Clinical System in metastatic breast cancer. The company established a global distribution network and expanded its pharma services business, securing repeat contracts and achieving ISO 15189 accreditation for its US clinical laboratory. Financially, ANGLE reported flat revenues of £1.0 million and an increased operating loss of £21.7 million due to planned investments in clinical studies and commercialization. To streamline operations and extend its cash runway into H2 2024, the company completed a £20.1 million capital raise and initiated the orderly wind-down of its Canadian facility.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees